Forget China And India, Clinical Trial Opportunities In Malaysia and South Korea
This article was originally published in PharmAsia News
Executive Summary
The opportunities for clinical trials in China and India are well known to the pharmaceutical industry at this point, but Edward Ian, senior director of clinical operations for PRA International-Asia Pacific, wants company leaders to take notice and advantage of the potential in other countries in Asia Pacific